April 24, 2025

Medical Oddities: Back Pain’s Cellular Villains Found?

Back pain’s got villains, green tea’s got perks, and empathy might outlast your logic this week.

Conexiant

April 23, 2025

AI Model Shows High Specificity and Sensitivity in DR Screening

Researchers urge developers for AI algorithms to monitor and publish their clinical performance for patient safety

Conexiant

April 18, 2025

Retinal Imaging Captures Alzheimer’s and Dementia Risk

The noninvasive, accessible, and scalable modality can predict risk before disease endpoints can be observed.

Conexiant

April 18, 2025

Improvements in OCT Imaging Performance, Processing, and Analysis 

“We can expect instruments to continue to improve as hardware does, and image analysis techniques to improve as more powerful machine learning algorithms are introduced,” study authors wrote.

Conexiant

April 17, 2025

FDA Reviews Eylea HD for RVO

The agency has initiated priority review of the anti-VEGF agent as a treatment for macular edema secondary to retinal vein occlusion.

Ophthalmology Management

April 16, 2025

Biocon, Regeneron Reach Agreement on Eylea Biosimilar

The agreement clears the way for Yesafili, an FDA-approved aflibercept biosimilar, to be commercialized in the United States.

Retinal Physician

April 16, 2025

Are Vision Outcomes Affected by Race in Ranibizumab Treatment for DME?

The 24-month endpoint evaluated BCVA and ETDRS letter gains

Conexiant

April 16, 2025

FDA Grants RMAT Status to Gene Therapy

Atsena Therapeutics received the designation for ATSN-201, a therapy intended to treat X-linked retinoschisis.

Retinal Physician

April 14, 2025

Macular Thickness as a Noninvasive Biomarker for Postoperative Delirium

Interocular asymmetry in retinal structure is common and may be influenced by hemispheric differences in neurodegeneration.

Conexiant